Skip to main content
. 2025 Oct 27;17:2441–2457. doi: 10.2147/CMAR.S540752

Table 2.

Clinicopathological Analysis of tRF5-23-GlyTCC-2

Parameter No. of Patients tRF5-23-GlyTCC-2 p value
High (n=61) Low (n=61)
Sex Male 63 29 34 0.365
Female 59 32 27
Age (year) >60 82 44 38 0.247
≤60 40 17 23
Tumor size >5 22 9 13 0.346
≤5 100 52 48
Differentiation grade Well-moderate 89 53 36 0.001
Poor 33 8 25
T stage T1-T2 49 32 17 0.006
T3-T4 73 29 44
Lymph node status Positive 66 26 40 0.011
Negative 56 35 21
TNM stage I–II 53 34 19 0.006
III–IV 69 27 42
Nerve/vascular-invasion Positive 53 20 33 0.018
Negative 69 41 28
C-erbB-2 Positive 38 16 22 0.241
Negative 84 45 39

Notes: *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.

Abbreviation: TNM, tumor node metastasis.